The Usfda Approves Glenmark Pharma S Tacrolimus Ointment

Top Stories

Company

L&T Partners with PS Technology to Revolutionise Railways

6 mins read. August 2, 2024 at 12:45 PM

Company

Jindal Saw Q1 FY24 PAT Rises 67% to Rs 441 Cr

4 mins read. August 2, 2024 at 12:41 PM

Company

Pfizer Q1 FY25 PAT Zooms 61% to Rs 151 Cr

4 mins read. August 2, 2024 at 12:36 PM

Stock chart

The USFDA approves Glenmark Pharma's Tacrolimus Ointment

ri-calendar-2-lineAug 17, 2023

By: BlinkX Research Team

FbkFbkTwitterTelegram

The generic version of Leo Pharma AS's Protopic1 Ointment, 0.03%, Tacrolimus Ointment, 0.03%, has been given final approval by the United States Food & Drug Administration (USFDA).

 

Glenmark Pharmaceuticals Inc., USA will sell Tacrolimus Ointment, 0.03%, in the US.

 

Glenmark now has 184 medications in its portfolio that are approved for sale in the US market, and 51 ANDA’s pending approval with the U.S. FDA.

 

The generic version of AstraZeneca's Onglyza1 tablets, Saxagliptin tablets (2.5 mg and 5 mg), was approved by the US Food & Drug Administration (US FDA) earlier this month.

 

Source: Media Reports

Related News

News Thumbnail
Company

L&T Partners with PS Technology to Revolutionise Railways

6 mins read. August 2, 2024 at 12:45 PM

News Thumbnail
Company

Jindal Saw Q1 FY24 PAT Rises 67% to Rs 441 Cr

4 mins read. August 2, 2024 at 12:41 PM

News Thumbnail
Company

Pfizer Q1 FY25 PAT Zooms 61% to Rs 151 Cr

4 mins read. August 2, 2024 at 12:36 PM

News Thumbnail
Company

NBCC Arm Gets Two Construction Projects Worth Rs 443.61 Cr

4 mins read. August 2, 2024 at 12:33 PM

Related Blogs

Stock chartIPO

CKK Retail Mart IPO Allotment Status Online

0 people read

5 mins read . Jan 30, 2026

Stock chartIPO

NFP Sampoorna Foods IPO Allotment Status Online

0 people read

4 mins read . Jan 30, 2026

Download app

Access BlinkX
everywhere
across device

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions